KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Cash & Equivalents (2016 - 2026)

Precigen has reported Cash & Equivalents over the past 15 years, most recently at $30.2 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 2.43% to $30.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.2 million through Dec 2025, up 2.43% year-over-year, with the annual reading at $30.2 million for FY2025, 2.43% up from the prior year.
  • Cash & Equivalents was $30.2 million for Q4 2025 at Precigen, up from $14.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $43.8 million in Q2 2022 and troughed at $4.9 million in Q4 2022.
  • The 5-year median for Cash & Equivalents is $17.0 million (2023), against an average of $21.5 million.
  • Year-over-year, Cash & Equivalents tumbled 86.66% in 2022 and then surged 289.51% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $36.4 million in 2021, then tumbled by 86.66% to $4.9 million in 2022, then surged by 55.99% to $7.6 million in 2023, then surged by 289.51% to $29.5 million in 2024, then grew by 2.43% to $30.2 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Cash & Equivalents are $30.2 million (Q4 2025), $14.3 million (Q3 2025), and $13.8 million (Q2 2025).